Quantum BioPharma Ltd. (QNTM) — Capital Reinvestment Ratio

Latest as of September 2018: 0.06x

Quantum BioPharma Ltd. (QNTM) has a Capital Reinvestment Ratio of 0.06x as of September 2018, meaning it reinvests 0% of its operating cash flow ($4.76 Million) in capital expenditures ($299.07K). See cash generation quality of Quantum BioPharma Ltd. to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

$4.76 Million

USD

Capital Expenditures

$299.07K

USD

Data as of

Sep 2018

Most recent filing

Annual Capital Reinvestment Ratio for Quantum BioPharma Ltd. (None–None)

Year-by-year Capital Reinvestment Ratio for Quantum BioPharma Ltd. from None to None. For the full cash flow conversion analysis, see Quantum BioPharma Ltd. cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow